AEON Biopharma, Inc. (AEON) has 4 open-market insider trades by 3 insiders since 2023. Over the last six months insiders net bought $243K. The most active filer is Jost Fischer, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Strathspey Crown Holdings Group, LLC | 10% Owner | — | 1 | $73.8M | 2023-08-11 |
| Timothy P. Lynch | 10% Owner | — | 1 | $243K | 2026-08-19 |
| Jost Fischer | Dir | — | 2 | $85K | 2026-06-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Timothy P. Lynch | 10% Owner | Buy | $243K | 2026-08-19 |
| Jost Fischer | Director | Buy | $29K | 2025-05-21 |
| Jost Fischer | Director | Buy | $56K | 2025-05-19 |
| Strathspey Crown Holdings Group, LLC | 10% Owner | Sell | $73.8M | 2023-08-11 |
Companies that share insiders with AEON, and sector peers with recent insider buying. Related by who files, not by how the stocks move.